Yay! Our reimbursement guide is now in its seventh edition
We have updated our guide to the reimbursement and pricing of pharmaceuticals in Europe. It is now in its seventh edition! Time flies! The guide also provides updated information on the harmonization of the benefit assessment of new therapies at the EU level. The new EU HTA procedure has been in effect since January 2025 and is one of the most far-reaching projects in the field of European pharmaceutical regulation in decades
The guide describes the pricing and reimbursement processes in France, Germany, Italy, Spain and the United Kingdom. It also contains data on the pharmaceutical markets and information on the marketing authorization procedures in Europe.
The guide is provided free of charge.
The IGES team and I hope you find it a useful read.